๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine

โœ Scribed by Arthur L. Brody; Sanjaya Saxena; Daniel H.S. Silverman; Lynn A. Fairbanks; Michael E. Phelps; Sung-Cheng Huang; Hsiao-Ming Wu; Karron Maidment; Lewis R. Baxter Jr.; Shervin Alborzian


Book ID
117618816
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
373 KB
Volume
91
Category
Article
ISSN
0925-4927

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Association between plasma paroxetine co
โœ Norio Yasui-Furukori; Shoko Tsuchimine; Taku Nakagami; Akira Fujii; Yasushi Sato ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 141 KB ๐Ÿ‘ 1 views

Recent studies have implicated brain-derived neurotrophic factor (BDNF) in the pathophysiology of depression and in the activities of antidepressant drugs. Serum BDNF levels are lower in depressed patients and increase in response to antidepressant medications; however, no studies have examined the